The Global South—Economic History and Health Systems Development
Mihajlo Jakovljevic 1,2,3,*,
Akihiko Ozaki 4,
Munjae Lee 5,
Tetsuya Tanimoto 6,
Tiago Correia 7,8,
João Paulo Teixeira 9,
Ronny Westerman 10,
Arcadio Cerda 11,
Narimasa Kumagai 12,
Chhabi Ranabhat 13,14,15,
Michael Talias 16,
Takashi Miyachi 17,
Resham Khatri 18,
Romanus Osabohien 19,20,
Jay Pan 21,
Pragyan Monalisa Sahoo 22,
Hao Hu 23,
María José Muñoz Torrecillas 24,25,
Morteza Arab-Zozani 26,
Yudai Kaneda 27,
Javad Javan-Noughabi 28,
Hui Jin 29,
Himanshu Sekhar Rout 30,31,
Leidy Garcia 11,
Erika Yamashita 6,
Charles Ezenduka 32,
Ajantha Sisira Kumara 33,
Eugene Kouassi 34,
Saeed Shahabi 35,
Wenqing Wu 36,
Chiranjivi Adhikari 37,38,
Makoto Kosaka 39,
Merhawi Gebremedhin Tekle 40,
Sulaiman Mouselli 41,
Tran Khanh Toan 42,
Salvador Cruz Rambaud 42,
Obinna Ikechukwu Ekwunife 43,
Tissa Wijeratne 44,
Vijay Kumar Chattu 45,46,
Lizheng Shi 47
Author Information
1 UNESCO-TWAS, The World Academy of Sciences, 34100 Trieste, Italy
2 Shaanxi University of Technology, Hanzhong 723099, China
3 Department of Global Health Economics and Policy, University of Kragujevac, 34000 Kragujevac, Serbia
4 Department of Breast and Thyroid Surgery, Jyoban Hospital of Tokiwa Foundation, Iwaki 972-8322, Japan
5 Department of Medical Science, Ajou University School of Medicine, Suwon 16499, Republic of Korea
6 Medical Governance Research Institute, Minato-ku, Tokyo 108-0074, Japan
7 Associate Laboratory in Translation and Innovation Towards Global Health (LA-REAL), Global Health and Tropical Medicine (GHTM), Instituto de Higiene e Medicina Tropical (IHMT), Universidade Nova de Lisboa (UNL), 1099-085 Lisbon, Portugal
8 WHO Collaborating Center on Health Workforce Policies and Planning, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, 1099-085 Lisbon, Portugal
9 Research Centre in Digitalization and Intelligent Robotics (CeDRI), Instituto Politecnico de Braganca, 5300-253 Braganca, Portugal
10 Federal Institute for Population Research, 65185 Wiesbaden, Germany
11 Faculty of Economics and Business, University of Talca, Talca 3460000, Chile
12 Faculty of Economics, Seinan Gakuin University, Fukuoka 814-0002, Japan
13 Health Promotion & Administration Program, College of Health Sciences, Eastern Kentucky University, Richmond, KY 40475, USA
14 Eastern Scientific LLC, Richmond, KY 40475, USA
15 Planetary Health Research Center, Kathmandu 44600, Nepal
16 Healthcare Management Program, School of Economics and Management, Open University of Cyprus, 2220 Nicosia, Cyprus
17 Department of Environmental Health Science and Public Health, Akita University Graduate School of Medicine, Akita 010-8543, Japan
18 School of Public Health, University of Queensland, Brisbane, QLD 4006, Australia
19 Institute of Energy Policy and Research (IEPRe), Universiti Tenaga Nasional (UNITEN), Kajang 43000, Malaysia
20 DePECOS Institutions and Development Research Centre (DIaDeRC), Ota 110125, Nigeria
21 West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu 610041, China
22 Health Technology Assessment-Regional Resource Hub (HTA-RRH), Indian Institute of Public Health, Gandhinagar 382010, Gujarat, India
23 Institute of Chinese Medical Sciences, University of Macau, Macao SAR, China
24 Department of Economics and Business, University of Almería, La Cañada de San Urbano s/n, 04120 Almería, Spain
25 Agrifood Campus of International Excellence, ceiA3, Mediterranean Research Center on Economics and Sustainable Development, CIMEDES, La Cañada de San Urbano s/n, 04120 Almería, Spain
26 Social Determinants of Health Research Center, Birjand University of Medical Sciences, Birjand 97178-53577, Iran
27 Epidemiology and Public Health, School of Medicine, Hokkaido University, Hokkaido 060-0811, Japan
28 The Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford OX2 6GG, UK
29 School of Economics and Management, Zhejiang Sci-Tech University, Hangzhou 310018, China
30 Department of Analytical & Applied Economics, Utkal University, Vani Vihar, Bhubaneswar 751004, Odisha, India
31 RUSA Centre of Excellence in Public Policy and Governance, Utkal University, Vani Vihar, Bhubaneswar 751004, Odisha, India
32 Department of Health Administration & Management, College of Medicine, University of Nigeria, Enugu Campus, Enugu 400006, Nigeria
33 Department of Public Administration, University of Sri Jayewardenepura, Nugegoda 10250, Sri Lanka
34 Department of Economics, Université Félix Houphouët-Boigny, Abidjan 22 BP 612, Côte d’Ivoire
35 Health Policy Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz 71348-45794, Iran
36 College of Management and Economics, Tianjin University, Tianjin 300072, China
37 School of Health and Allied Sciences (SHAS), Pokhara University, Pokhara 33700, Nepal
38 Indian Institute of Public Health Gandhinagar (IIPHG), Gandhinagar 382010, Gujarat, India
39 Imamura Hospital Kagoshima, Kagoshima 890-0064, Japan
40 School of Public Health, Haramaya University, Harar 3200, Ethiopia
41 Faculty of Business Administration, Arab International University, Ghabagheb, Syria
42 Departamento de Economía y Empresa, Universidad de Almería, 04120 Almería, Spain
43 Division of Population Health, Department of Medicine, The University at Buffalo, State University of New York, Buffalo, NY 14203, USA
44 Department of Neurology and Stroke, Western Health, Victoria 3021, Australia
45 ReSTORE Lab, Department of OS & OT, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada
46 Prasanna School of Public Health, Manipal Academy of Higher Education (MAHE), Manipal 576104, Karnataka, India
47 Department of Health Policy and Management, Celia Scott Weatherhead School of Public Health and Tropical Medicine, Tulane University, New Orleans, LA 70118, USA
Correspondence: sidartagothama@gmail.com
Received: 20 Oct 2025 | Revised: 12 Dec 2025 | Accepted: 06 Jan 2026 | Published: 12 Jan 2026
Abstract
The low-and-middle-income-countries (LMICs) of the Global South witness rapid health system development with substantial heterogeneity of affordability of medical care. Financial sustainability challenge is hard to understand without knowledge of economic history. Centuries have witnessed Colonialization, slave trade, world wars, Cold War, Non-Aligned Movement and Colonial Liberation Movements. Painful legacy shaped contemporary economic growth, and ability to invest in healthcare. There is expanding demand for health workforce-to-population ratio and supply of essential pharmaceuticals and medical devices. Despite rapid expansion of the middle class throughout the Global South, out-of-pocket spending remains excessive, while catastrophic healthcare expenditure is widespread. Most of the newly established welfare and abundance of disposable resources for healthcare investment are centered among the BRICS countries (Brazil, Russia, India, China, and South Africa). Despite significant health expenditure growth in PPP terms, LMICs’ insufficiently prioritize medicine in budgetary spending. Global South inability to meet ever-rising demand for medical care will remain constrained by wide socioeconomic inequalities and vulnerability of the poor. Sustained economic growth requires strategic interventions that prioritize equitable healthcare access and financial toxicity protection. Without comprehensive reforms that account for historical legacies and resource constraints, the promise of universal health coverage in the Global South will remain elusive.
Gray, K.; Gills, B.K. South–South cooperation and the rise of the Global South. Third World Q. 2016, 37, 557–574.
2.
Chant, S.H.; McIlwaine, C. Geographies of Development in the 21st Century: An Introduction to the Global South; Edward Elgar Publishing: Cheltenham, UK, 2009.
3.
Blaut, J.M. 1492: The Debate on Colonialism, Eurocentrism, and History; Africa World Press: Trenton, NJ, USA, 1992.
4.
Peters, M.A. The ancient Silk Road and the birth of merchant capitalism. Educ. Philos. Theory 2021, 53, 955–961.
5.
Burchett, J. A Complete History of the Most Remarkable Transactions at Sea, from the Earliest Accounts of Time to the Conclusion of the Last War with France: Wherein is Given an Account of the... Naval-expeditions, Sea-fights, Stratagems, Discoveries, and Other Maritime Occurences That Have Happen’d Among All Nations Which Have Flourished at Sea; and in a More Particular Manner of Great Britain...: in Five Books; Printed by WB for J. Walthoe and J. Walthoe Junior: London, UK, 1720.
6.
Thompson, T.L. Jerusalem in Ancient History and Tradition; Torrossa: Florence, Italy, 2004; 280p.
7.
Groumpos, P.P. A critical historical and scientific overview of all industrial revolutions. IFAC-Pap. 2021, 54, 464–471.
8.
Spear, B. James Watt: The steam engine and the commercialization of patents. World Pat. Inf. 2008, 30, 53–58.
9.
Fage, J.D. Slavery and the slave trade in the context of West African history. J. Afr. Hist. 1969, 10, 393–404.
10.
Stannard, D. American Holocaust; Oxford University Press: New York, NY, USA, 1992; ISBN 978-0-19-508557-0.
11.
History of Slavery. Available online: https://www.sources.com/SSR/Docs/SSRW-History_Slavery.htm (accessed on 19 October 2025)
12.
Meena, H.K. The Meaning and Methods of Drain of Wealth in Colonial India. Int. Res. J. Manag. IT Soc. Sci. 2016, 3, 65–72.
13.
Bell, N.M. The Age of Mansa Musa of Mali: Problems in succession and chronology. Int. J. Afr. Hist. Stud. 1972, 5, 221–234.
14.
Polo, M. The Travels of Marco Polo, the Venetian; No. 306; JM Dent: London, UK, 1927.
15.
Manning, P. The Maddison project: Historical GDP estimates worldwide. J. World-Hist. Inf. 2017, 3–4. https://doi.org/10.5195/jwhi.2017.46.
16.
Neff, S.C. Decline and emergence: Roman law and the transition from antiquity to feudalism. J. Leg. Hist. 1984, 5, 91–116.
17.
Crafts, N.F. Industrial Revolution in England and France: Some thoughts on the question, “Why was England first?” Econ. Hist. Rev. 1977, 30, 429–441.
18.
Voigtländer, N.; Voth, H.-J. Why England? Demographic factors, structural change and physical capital accumulation during the Industrial Revolution. J. Econ. Growth 2006, 11, 319–361.
19.
Jakovljevic, M.; Cerda, A.A.; Liu, Y.; et al. Sustainability challenge of Eastern Europe—Historical legacy, belt and road initiative, population aging and migration. Sustainability 2021, 13, 11038.
20.
Jakovljevic, M. Population ageing alongside health care spending growth. Srp. Arh. Za Celok. Lek. 2017, 145, 534–539. https://doi.org/10.2298/SARH160906113J.
21.
Wardwell, J.M. Toward a Theory of Urban-Rural Migration in the Developed World. In New Directions in Urban-Rural Migration: The Population Turnaround in rural America; Academic Press: New York, NY, USA, 1980; 71.
22.
Jakovljevic, M.M.; Netz, Y.; Buttigieg, S.C.; et al. Population aging and migration–history and UN forecasts in the EU-28 and its east and south near neighborhood–one century perspective 1950–2050. Glob. Health 2018, 14, 1–6.
23.
Chatterjee, A.; Chattopadhyay, R.N.; Chatterjee, A.; et al. Growth of metropolises and megacities with focus on global south. Satellite Towns in Neo-metropolitan Development in India: Lessons from Selected Cities. J. Urban Aff. 2020, 45, 797–814.
24.
Goldstone, J.A. The Wealth and Poverty of Nations: Why Some Are So Rich and Others So Poor. J. World Hist. 2000, 11, 105–111.
25.
Palat, R.A. World Turned Upside Down? Rise of the global South and the contemporary global financial turbulence. Third World Q. 2010, 31, 365–384.
26.
Gandhi, M. All Men Are Brothers: Life and Thoughts of Mahatma Gandhi as Told in His Own Words; Columbia University Press: New York, NY, USA, 1953. https://doi.org/10.7312/gand90224-006.
27.
Mandela, N. The Struggle Is My Life: His Speeches and Writings Brought Together with Historical Documents and Accounts of Mandela in Prison by Fellow-Prisoners; Popular Prakashan; IDAF Publications: London, UK, 1990.
28.
Rampazzo, B. Le devenir Afrique de Lumumba, Nkrumah et Sankara. Ou de l’importance de ressasser le passé contre le discours de Dakar: Pages: 218–237. Philos. Soc. 2012, 23. https://doi.org/10.2298/FID1204218R.
29.
Lüthi, L.M. The non-aligned movement and the cold war, 1961–1973. J. Cold War Stud. 2016, 18, 98–147.
30.
Simonia, N.A. National liberation movements and the collapse of colonialism. In History of Humanity: The Twentieth Century 7; Government of India Mission to ASEAN: Jakarta, Indonesia, 1994; pp. 56–61.
31.
Berryman, P. Liberation Theology: Essential Facts about the Revolutionary Movement in Latin America—And Beyond; Temple University Press: Philadelphia, PA, USA, 1987.
32.
Andjembe Etogho, E.B.; Eben, S.E.M.; Dalton, A.L. French neocolonialism in Africa: Historical overview and summary of current events. Am. J. Econ. Sociol. 2022, 81, 829–849.
33.
Musa, A.A.; Awudu, A.D.; Elijah, E. Neo-Colonialism and Dependent Development in African Countries: A Critical Analysis of Nigeria’s Neo-Colonial Status. Kashere J. Politics Int. Relat. 2025, 3, 283–295.
34.
Yoon, T.-R. Historical animosity is what states make of it: The role of morality and realism in Korea-Japan relations. Korean J. Int. Stud. 2011, 9, 1–37.
35.
Bull, H. The great irresponsibles? The United States, the Soviet Union, and world order. Int. J. 1980, 35, 437–447.
36.
Lu, X.; Li, R. South-South cooperation: Is there a foundation in trade? J. Chin. Econ. Foreign Trade Stud. 2010, 3, 221–234.
37.
Hurrell, A. Narratives of emergence: Rising powers and the end of the Third World? Braz. J. Political Econ. 2013, 33, 203–221.
38.
The Voice of Global South Summit: Participation of ASEAN Member States. Available online: https://www.indmissionasean.gov.in/press_india?id=dPjza (accessed on 19 October 2025).
39.
Kumar, S. India’s G20 Presidency as a Voice of Global South; RIS, Research and Information System for Developing Countries: New Delhi, India, 2024.
40.
Dinkel, J. The Non-Aligned Movement: Genesis, Organization and Politics (1927–1992); Brill: Leiden, The Netherlands, 2018; Volume 5.
41.
Finance Center for South-South Cooperation. Available online: http://www.fc-ssc.org/en (accessed on 19 October 2025).
42.
The Group of 77.Available online: https://www.g77.org/ (accessed on 19 October 2025).
43.
Tulchinsky, T.H. Bismarck and the long road to universal health coverage. Case Stud. Public Health 2018, 131–179. https://doi.org/10.1016/B978-0-12-804571-8.00031-7.
44.
Jacobs, J. An introduction to the Beveridge Report. In Understanding Health and Social Care: An Introductory Reader; SAGE Publications: Thousand Oaks, CA, USA, 2008.
45.
Semenova, Y.; Lim, L.; Salpynov, Z.; et al. Historical evolution of healthcare systems of post-soviet Russia, Belarus, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Armenia, and Azerbaijan: A scoping review. Heliyon 2024, 10, e29550. https://doi.org/10.1016/j.heliyon.2024.e29550.
46.
Reshetnikov, V.; Arsentyev, E.; Bolevich, S.; et al. Analysis of the financing of Russian health care over the past 100 years. Int. J. Environ. Res. Public Health 2019, 16, 1848.
47.
Hariri, J.G. The autocratic legacy of early statehood. Am. Political Sci. Rev. 2012, 106, 471–494.
48.
Santini, R.H.; Polese, A.; Kevlihan, R. (Eds.) Limited Statehood and Informal Governance in the Middle East and Africa; Routledge, Taylor & Francis Group: London, UK, 2021.
49.
Allahham, L.; Mouselli, S.; Jakovljevic, M. The quality of Syrian healthcare services during COVID-19: A HEALTHQUAL approach. Front. Public Health 2022, 10, 970922.
50.
Nelson, M.A.; Singh, R.D. The deficit-growth connection: Some recent evidence from developing countries. Econ. Dev. Cult. Chang. 1994, 43, 167–191.
51.
Reeves, A.; Basu, S.; McKee, M.; et al. Does investment in the health sector promote or inhibit economic growth? Glob. Health 2013, 9, 43.
52.
Panda, H.S.; Rout, H.S.; Jakovljevic, M. Catastrophic health expenditure of inpatients in emerging economies: Evidence from the Indian subcontinent. Health Res. Policy Syst. 2024, 22, 104.
53.
Miyachi, T.; Ozaki, A.; Jakovljevic, M.; et al. Fiscal Resilience and Equity: Analyzing Japan’s Tax Strategy for Post-Disaster Reconstruction. Int. J. Disaster Risk Reduct. 2025, 118, 105228.
54.
Otieno, E.; Seeiso, T.; Businge, J.; et al. Achieving universal health coverage in Sub-Saharan Africa through the reformation of mental health financing. Glob. Health Econ. Sustain. 2025, 3, 21–27 https://doi.org/10.36922/ghes.3700.
55.
Kalita, A.; Carton-Rossen, N.; Joseph, L.; et al. The Barriers to Universal Health Coverage in India and the Strategies to Address Them: A Key Informant Study. Ann. Glob. Health 2023, 89, 69. https://doi.org/10.5334/aogh.4120.
56.
Jyani, G.; Gedam, P.; Sharma, S.; et al. Financial Viability of Private Hospitals Operating Under India’s National Health Insurance Scheme Ayushman Bharat Pradhan Mantri-Jan Arogya Yojana (AB PM-JAY). Appl. Health Econ. Health Policy 2025, 23, 841–853. https://doi.org/10.1007/s40258-025-00966-9.
57.
Khan, M.A. Livelihood, WASH related hardships and needs assessment of climate migrants: Evidence from urban slums in Bangladesh, Heliyon 2022, 8, e09355. https://doi.org/10.1016/j.heliyon.2022.e09355.
58.
Jakovljevic, M.; Deceuninck, P.; Pistollato, F.; et al. Return on investment in science: Twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer. Cost Eff. Resour. Alloc. 2024, 22, 51.
59.
Fenollar, F.; Mediannikov, O. Emerging infectious diseases in Africa in the 21st century. New Microbes New Infect. 2018, 26, S10–S18.
60.
Jakovljevic, M.; Al Ahdab, S.; Jurisevic, M.; et al. Antibiotic resistance in Syria: A local problem turns into a global threat. Front. Public Health 2018, 6, 212.
61.
Vecchio, F.B.D.; Barbosa, E.P.; Cantu, R. Max Weber and Harriet Martineau in physical education: Nuances of historical parallelism and gender bias in the sociological method. Glob. Health Econ. Sustain. 2023, 1, 0992. https://doi.org/10.36922/ghes.0992.
62.
Popkin, B.M.; Ng, S.W. The nutrition transition to a stage of high obesity and noncommunicable disease prevalence dominated by ultra-processed foods is not inevitable. Obes. Rev. 2022, 23, e13366.
63.
Alkholidy, G.G.; Anam, L.S.; Al Serouri, A.; et al. Non-communicable diseases household survey data analysis in Sana’a City, Yemen, 2017. Glob. Health Econ. Sustain. 2023, 1, 1191. https://doi.org/10.36922/ghes.1191.
64.
Jakovljevic, M.; Kozlova, O.; Makarova, M.; et al. Partial contribution of socioeconomic factors to the mortality rate of the working-age population in Russia. Healthcare 2023, 11, 1507.
65.
Goda, E.T.; Boshera, T.D.; Aredo, M.K. Examining the relationship between urban household food Insecurity and under-five mortality in Lideta Sub-city, Addis Ababa, Ethiopia. Glob. Health Econ Sustain 2024, 2, 1682. https://doi.org/10.36922/ghes.1682.
66.
Kovačević, A.; Dragojević-Simić, V.; Rančić, N.; et al. End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit. Pregl. 2015, 72. https://doi.org/10.2298/5439.
67.
Amza, A. Sustainability of specialized healthcare in economies like Jamaica: Overcoming historical constraints. Glob. Health Econ. Sustain. 2024, 2, 2709. https://doi.org/10.36922/ghes.2709.
68.
Liu, L. Economic uncertainty and population health: Insights from emerging markets and developing countries. Front. Public Health 2023, 11, 1292236.
69.
Chen, X.; Cai, K.; Xue, Y.; et al. Using system dynamics modeling approach to strengthen health systems to combat cancer: A systematic literature review. J. Med. Econ. 2025, 28, 168–185.
70.
Shi, L.; Xuan, D.; Jakovljevic, M. A review on the evolving environment of medical device real-world evidence regulation on market access in the USA. Cost Eff. Resour. Alloc. 2024, 22, 75.
71.
Jakovljevic, M.; Sahoo, P.M.; Rout, H.S. Health expenditure and fiscal marksmanship before and during the coronavirus pandemic across the federal states of India. Glob. Health Econ. Sustain. 2025, 3, 135–149. https://doi.org/10.36922/ghes.2920.
72.
Blackstone, E.A.; Fuhr, J.P., Jr.; Pociask, S. The health and economic effects of counterfeit drugs. Am. Health Drug Benefits 2014, 7, 216.
73.
Glass, B.D. Counterfeit drugs and medical devices in developing countries. Res. Rep. Trop. Med. 2014, 5, 11–22.
74.
Fantasia, H.C.; Vooys, K.M. Public health implications of counterfeit medications. Nurs. Women’s Health 2018, 22, 264–268.
75.
Delepierre, A.; Gayot, A.; Carpentier, A. Update on counterfeit antibiotics worldwide; public health risks. Med. Mal. Infect. 2012, 42, 247–255.
76.
Mackey, T.K.; Liang, B.A. Improving global health governance to combat counterfeit medicines: A proposal for a UNODC-WHO-Interpol trilateral mechanism. BMC Med. 2013, 11, 233.
77.
Mackey, T.K.; Liang, B.A. The global counterfeit drug trade: Patient safety and public health risks. J. Pharm. Sci. 2011, 100, 4571–4579.
78.
Hamilton, W.L.; Doyle, C.; Halliwell-Ewen, M.; et al. Public health interventions to protect against falsified medicines: A systematic review of international, national and local policies. Health Policy Plan. 2016, 31, 1448–1466.
79.
Martí Selva, M.L.; Puertas Medina, R.M. Determinants of the imports of essential medical products by European Union. Glob. Health Econ. Sustain. 2023, 1. https://doi.org/10.36922/ghes.1207.
80.
Awor, P.; Kinengyere, A.A. Delivering maternal and child health interventions through the private sector in LMIC: A scoping review of strategies and effective approaches. BMJ Public Health 2023, 1, e000088. https://doi.org/10.1136/bmjph-2023-000088.
81.
Kodali, P.B. Achieving Universal Health Coverage in Low- and Middle-Income Countries: Challenges for Policy Post-Pandemic and Beyond. Risk Manag. Healthc. Policy 2023, 16, 607–621. https://doi.org/10.2147/RMHP.S366759.
82.
Idris, F.M.; Seraj, M.; Ozdeser, H. Impact of health expenditure on poverty in low- and middle-income countries: An autoregressive distributed lag bounds approach. Glob. Health Econ. Sustain. 2024, 2, 2383. https://doi.org/10.36922/ghes.2383.
83.
Jakovljevic, M.; Lamnisos, D.; Westerman, R.; et al. Future health spending forecast in leading emerging BRICS markets in 2030: Health policy implications. Health Res. Policy Syst. 2022, 20, 23.
84.
Arapova, E.Y.; Lissovolik, Y.D. The BRICS plus cooperation in international organizations: Prospects for reshaping the global agenda. Asia-Pac. Soc. Sci. Rev. 2021, 21, 14.
85.
Li, J.; Xu, Z.; Wang, H.; et al. Geospatial analysis of spatial distribution, patterns, and relationships of health status in the belt and road initiative. Sci. Rep. 2024, 14, 204.
86.
Amza, A. Sustainability of specialized healthcare in upper-middle-income economies: Innovations despite constraints. Glob. Health Econ. Sustain. 2024, 2, 2717. https://doi.org/10.36922/ghes.2717.
87.
Gasper, D. The road to the sustainable development goals: Building global alliances and norms. J. Glob. Ethics 2019, 15, 118–137.
88.
Stevens, H.; Huys, I. Innovative approaches to increase access to medicines in developing countries. Front. Med. 2017, 4, 218. https://doi.org/10.3389/fmed.2017.00218.
89.
Dinh, S.; Yin, W.; Sifre-Acosta, N.; et al. COVID-19 pandemic health expenditures and family economic behaviors: China health and retirement longitudinal study (CHARLS). Glob. Health Econ. Sustain. 2025, 3, 203–213. https://doi.org/10.36922/ghes.6619.
90.
Niëns, L.M.; Cameron, A.; Van de Poel, E.; et al. Quantifying the impoverishing effects of purchasing medicines: A cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010, 7, e1000333.
91.
Choi, H.C.; Lam, K.O.; Pang, H.H.; et al. Global comparison of cancer outcomes: Standardization and correlation with healthcare expenditures. BMC Public Health 2019, 19, 1065.
92.
Johnston, K.; Guingona, M.; Elsanousi, S.; et al. Training a fit-for-purpose rural health workforce for low-and middle-income countries (LMICs): How do drivers and enablers of rural practice intention differ between learners from LMICs and high income countries? Front. Public Health 2020, 8, 582464.
93.
Jakovljevic, M.; Sharma, T.; Kumagai, N.; et al. NCDs–core challenge of modern day health care establishments. Front. Public Health 2021, 9, 692926. https://doi.org/10.3389/fpubh.2021.692926.
94.
Al Ahdab, S. A cross-sectional survey of knowledge, attitude and practice (KAP) towards COVID-19 pandemic among the Syrian residents. BMC Public Health 2021, 21, 296.
95.
Leech, A.A.; Kim, D.D.; Cohen, J.T.; et al. Are low and middle-income countries prioritising high-value healthcare interventions? BMJ Glob. Health 2020, 5, e001850.
96.
Jakovljevic, M.; Timofeyev, Y.; Zhuravleva, T. The impact of pandemic-driven care redesign on hospital efficiency. Risk Manag. Healthc. Policy 2024, 17, 1477–1491.
97.
Timofeyev, Y.; Jakovljevic, M. Fraud and corruption in healthcare. Front. Public Health 2022, 10, 921254. https://doi.org/10.3389/fpubh.2022.921254.
98.
Ozaki, A.; Larkin, J.; Sakata, N.; et al. Unveiling, analyzing the mechanisms of, and proposing solutions for bribery in Japan’s medical device sector. Cureus 2024, 16, e61285.
99.
Hutson, J.; Hutson, P. Neuroinclusive workplaces and biophilic design: Strategies for promoting occupational health and sustainability in smart cities. Glob. Health Econ. Sustain. 2023, 1, 491. https://doi.org/10.36922/ghes.0549.
100.
Kindle, R.D.; Badawi, O.; Celi, L.A.; et al. Intensive care unit telemedicine in the era of big data, artificial intelligence, and computer clinical decision support systems. Crit. Care Clin. 2019, 35, 483–495.
101.
Atmojo, J.T.; Sudaryanto, W.T.; Widiyanto, A.; et al. Telemedicine, cost effectiveness, and patients satisfaction: A systematic review. J. Health Policy Manag. 2020, 5, 103–107.
102.
Jakovljevic, M.; Sugahara, T.; Timofeyev, Y.; et al. Predictors of (in) efficiencies of healthcare expenditure among the leading as an economies–comparison of OECD and non-OECD nations. Risk Manag. Healthc. Policy 2020, 13, 2261–2280.
103.
John, D.; Majumdar, A.D.; Pillai, R.N.; et al. Health technology assessment for digital health Technologies in India: A framework for action. Int. J. Technol. Assess. Health Care 2024, 40, e70.
104.
Christine, C. Huttin. Are random price generators useful for health policy processes and analysis? effectiveness of random price generators in health policy processes and analysis. Glob. Health Econ. Sustain. 2025, 3, 28–36. https://doi.org/10.36922/ghes.3579.
105.
Kumar, A.S.; Chen, L.C.; Choudhury, M.; et al. Financing health care for all: Challenges and opportunities. Lancet 2011, 377, 668–679.
106.
Leighl, N.B.; Nirmalakumar, S.; Ezeife, D.A.; et al. (2021). An arm and a leg: The rising cost of cancer drugs and impact on access. In American Society of Clinical Oncology Educational Book; ASCO Publications: Alexandria, VA, USA, 2021; Volume 41, pp. 1–12.
107.
Barrios, C.; de Lima Lopes, G.; Md Yusof, M.; et al. Barriers in access to oncology drugs—A global crisis. Nat. Rev. Clin. Oncol. 2023, 20, 7–15.
108.
Yenet, A.; Nibret, G.; Tegegne, B.A. Challenges to the availability and affordability of essential medicines in African countries: A scoping review. Clin. Outcomes Res. 2023, 15, 443–458.
109.
Borin, M.C.; Barbosa, M.M.; Pereira, C.O.; et al. Budgetary impact of new label indications after initial drug registration in Brazil: A case study of pembrolizumab and trastuzumab deruxtecan. Glob. Health Econ. Sustain. 2023, 1, 0994. https://doi.org/10.36922/ghes.0994.
110.
Lexchin, J. Profits first, health second: The pharmaceutical industry and the Global South: Comment on “More pain, more gain! The delivery of COVID-19 vaccines and the pharmaceutical industry’s role in widening the access gap”. Int. J. Health Policy Manag. 2024, 13, 8471.
111.
Barber, M.J.; Gotham, D.; Bygrave, H.; et al. Estimated sustainable cost-based prices for diabetes medicines. JAMA Netw. Open 2024, 7, e243474.
112.
Ghosh, M.; Yadav, A.K.; Sahni, B. Income inequalities in maternal health-care service utilization in India: Applying the Blinder–Oaxaca decomposition method. Glob. Health Econ. Sustain. 2025, 3, 92–101. https://doi.org/10.36922/ghes.3324.
113.
Binagwaho, A.; Mathewos, K.; Davis, S. Time for the ethical management of COVID-19 vaccines. Lancet Glob. Health 2021, 9, e1169–e1171.
114.
Borin, M.C.; Barbosa, M.M.; Pereira, C.O.; et al. Assessing the impact of fast-track drug registration by Anvisa in Brazil: A descriptive study of new drug registrations from 2017 to 2022. Glob. Health Econ. Sustain. 2023, 1, 0995. https://doi.org/10.36922/ghes.0995.
115.
World Trade Organization. Uruguay Round Agreement: TRIPS—Agreement on Trade-Related Aspects of Intellectual Property Rights (unamended). Marrakesh Agreement Establishing the World Trade Organization, Annex 1C. 1994. Available online: https://www.wto.org/english/docs_e/legal_e/27-trips.pdf (accessed on 25 September 2025).
116.
Kohler, J.; Wong, A.; Tailor, L. Improving access to COVID-19 vaccines: An analysis of TRIPS waiver discourse among WTO members, civil society organizations, and pharmaceutical industry stakeholders. Health Hum. Rights 2022, 24, 159–175.
117.
Odo, O.K.; Gulma, K.A.; & Audi, M. Optimizing last-mile delivery of essential medicines in Nigeria: Insights from Niger State’s Healthcare supply chain. Glob. Health Econ. Sustain. 2024, 3, 185–196. https://doi.org/10.36922/ghes.4714.
118.
World Health Organization. Essential Medicines. 25 September 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/essential-medicines (accessed on 25 September 2025).
119.
Torreele, E. Why are our medicines so expensive? Spoiler: Not for the reasons you are being told…. J. Gen. Pract. 2024, 30, 2308006.
120.
Jakovljevic, M.; Liu, Y.; Cerda, A.; et al. The Global South political economy of health financing and spending landscape—History and presence. J. Med. Econ. 2021, 24, 25–33.
121.
Oldfield, L.; Penm, J.; Mirzaei, A.; et al. Prices, availability, and affordability of adult medicines in 2025, 54 low-income and middle-income countries: Evidence based on a secondary analysis. Lancet Glob. Health 2025, 13, e50–e58.
122.
Collins, L.; Ross, L.; Preston, M. Cost-effectiveness of promoting population health management through education, seminars, and participatory learning for individuals diagnosed with chronic diseases. Glob. Health Econ. Sustain. 2025, 3, 64–68. https://doi.org/10.36922/ghes.3089.
123.
Lavtepatil, S.; Ghosh, S. Improving access to medicines by popularising generics: A study of ‘India’s People’s Medicine’ scheme in two districts of Maharashtra. BMC Health Serv. Res. 2022, 22, 643. https://doi.org/10.1186/s12913-022-08022-1.
124.
Chen, Y.; Huang, Z. Differences between the quality aspects of various generic and branded docetaxel formulations. Curr. Med. Res. Opin. 2021, 37, 1421–1433. https://doi.org/10.1080/03007995.2021.1929895.
125.
Lam, D. How the world survived the population bomb: Lessons from 50 years of extraordinary demographic history. Demography 2011, 48, 1231–1262.
126.
Gu, D.; Andreev, K.; Dupre, M.E. Major trends in population growth around the world. China CDC Wkly. 2021, 3, 604.
127.
Allyn, D. Make Love, Not War: The Sexual Revolution: An Unfettered History; Routledge: New York, NY, USA, 2016. https://doi.org/10.4324/9781315539768.
128.
Shorter, E. Female emancipation, birth control, and fertility in European history. Am. Hist. Rev. 1973, 78, 605–640.
129.
Maier, C.S. The Cold War as an era of imperial rivalry. In Reinterpreting the End of the Cold War; pp. 13–20. Routledge: New York, NY, USA, 2014.
130.
Hemmati, R.; Saboori, H.; Jirdehi, M.A. Multistage generation expansion planning incorporating large scale energy storage systems and environmental pollution. Renew. Energy 2016, 97, 636–645.
131.
Kao, J. Innovation Nation: How America Is Losing Its Innovation Edge, Why It Matters, and What We Can Do to Get It Back; Simon and Schuster: New York, NY, USA, 2007.
132.
Tregubov, V.N. Publication activity of researchers about the NA Semashko’s life and activity Health Сare Russ. Fed. 2024, 68, 241–246.
133.
Jakovljevic, M.; Ogura, S. Health economics at the crossroads of centuries–from the past to the future. Front. Public Health 2016, 4, 115. https://doi.org/10.3389/fpubh.2016.00115.
134.
Jensen, S.K.; Bouhouch, R.R.; Walson, J.L.; et al. Enhancing the child survival agenda to promote, protect, and support early child development. Semin. Perinatol. 2015, 39, 373–386.
135.
Jasseh, M. Age Patterns of Mortality within Childhood in Sub-Saharan Africa. Doctoral Dissertation, London School of Hygiene & Tropical Medicine, London, UK, 2003.
136.
Jakovljevic, M.; Péntek, M.; Wijeratne, T.; et al. Accelerated globalization and its impact to the world’s Health Care Achievement. Front. Public Health 2021, 9, 690239. https://doi.org/10.3389/fpubh.2021.690239.
137.
Jakovljevic, M.B. BRIC’s growing share of global health spending and their diverging pathways. Front. Public Health 2015, 3, 135. https://doi.org/10.3389/fpubh.2015.00135.
138.
Jakovljevic, M.; Chang, H.; Pan, J.; et al. Successes and challenges of China’s health care reform: A four-decade perspective spanning 1985—2023. Cost Eff. Resour. Alloc. 2023, 21, 59.
139.
Hogg, W.; Baskerville, N.; Lemelin, J. Cost savings associated with improving appropriate and reducing inappropriate preventive care: Cost-consequences analysis. BMC Health Serv. Res. 2005, 5, 20.
140.
Rahman, T.; Gasbarro, D.; Alam, K. Financial risk protection from out-of-pocket health spending in low-and middle-income countries: A scoping review of the literature. Health Res. Policy Syst. 2022, 20, 83.
141.
Sumner, A. The Buoyant Billions: How’Middle Class’ are the New Middle Classes in Developing Countries? (And Why Does it Matter?). Center for Global Development Working Paper 309. 2012. Available online: https://ssrn.com/abstract=2226568 (accessed on 25 September 2025).
142.
Schrecker, T. (2021). Health inequalities and development in a global context. In The Essential Guide to Critical Development Studies; Routledge: London, UK, 2021; pp. 213–221.
143.
Guy-Frank, C.J.; Persaud, K.; Butsenko, D.; et al. Developing a sustainable renal transplant program in low-and middle-income countries: Outcome, challenges, and solutions. World J. Surg. 2019, 43, 2658–2665.
144.
Cui, A.P.; Wajda, T.A.; Walsh, M.F. Luxury brands in emerging markets: A case study on China. In Entrepreneurship in International Marketing; Emerald Group Publishing Limited: Bingley, UK, 2015; pp. 287–305.
145.
Khan, M.A.; Ul Husnain, M.I. Is health care a luxury or necessity good? Evidence from Asian countries. Int. J. Health Econ. Manag. 2019, 19, 213–233.
146.
Sumner, A. Poverty, vulnerability and class: The expanding non-polar groups and development. Public Adm. Dev. 2012, 32, 444–454.
147.
Petrou, S.; Jakovljevic, M. Reimagining the relationship between economics and health—WHO ‘Health for all’ provisions. Cost Eff. Resour. Alloc. 2024, 22, 5. https://doi.org/10.1186/s12962-024-00512-9.
148.
Ogura, S.; Jakovljevic, M. Health financing constrained by population aging-an opportunity to learn from Japanese experience. Serbian J. Exp. Clin. Res. 2014, 15, 175–181 https://doi.org/10.2478/SJECR-2014-0022.
149.
Luo, Y.; Su, B.; Zheng, X. Trends and challenges for population and health during population aging—China, 2015–2050. China CDC Wkly. 2021, 3, 593.
150.
Katoue, M.G.; Cerda, A.A.; García, L.Y.; et al. Healthcare system development in the Middle East and North Africa region: Challenges, endeavors and prospective opportunities. Front. Public Health 2022, 10, 1045739. https://doi.org/10.3389/fpubh.2022.1045739.
151.
Jakovljevic, M.; Jakab, M.; Gerdtham, U.; et al. Comparative financing analysis and political economy of noncommunicable diseases. J. Med. Econ. 2019, 22, 722–727.
152.
Jakovljevic, M. Therapeutic innovations: The future of health economics and outcomes research–increasing role of the Asia-Pacific. J. Med. Econ. 2021, 24, i–iii. https://doi.org/10.1080/13696998.2021.2014164.
153.
Allen, L.N.; Pullar, J.; Wickramasinghe, K.K.; et al. Evaluation of research on interventions aligned to WHO ‘Best Buys’ for NCDs in low-income and lower-middle-income countries: A systematic review from 1990 to 2015. BMJ Glob. Health 2018, 3, e000535..
154.
Nash, C. Promoting sustainability through equality, peace, and justice: A luck-dependent decision-making practice in an economically successful intentional community. Glob. Health Econ. Sustain. 2024, 2, 3191. https://doi.org/10.36922/ghes.3191.
155.
Raghupathi, W.; Wu, S.J.; Raghupathi, V. Exploring the association between gender inequality and healthcare: A visualization study. Glob. Health Econ. Sustain. 2025, 3, 188–202. https://doi.org/10.36922/ghes.5776.
156.
Jakovljevic, M.; Wu, W.; Merrick, J.; et al. Asian innovation in pharmaceutical and medical device industry–beyond tomorrow. J. Med. Econ. 2021, 24, 42–50.
157.
Mashamba-Thompson, T.P.; Jama, N.A.; Sartorius, B.; et al. Implementation of point-of-care diagnostics in rural primary healthcare clinics in South Africa: Perspectives of key stakeholders. Diagnostics 2017, 7, 3.
158.
Cerda, A.A.; García, L.Y.; Rivera-Arroyo, J.; et al. Comparison of the healthcare system of Chile and Brazil: Strengths, inefficiencies, and expenditures. Cost Eff. Resour. Alloc. 2022, 20, 71.
159.
Barnes, R.; Zvarikova, K. Artificial intelligence-enabled wearable medical devices, clinical and diagnostic decision support systems, and Internet of Things-based healthcare applications in COVID-19 prevention, screening, and treatment. Am. J. Med. Res. 2021, 8, 9–22.
160.
Croll, E.J. The intergenerational contract in the changing Asian family. Oxf. Dev. Stud. 2006, 34, 473–491.
161.
Su, Z.; Bentley, B.L.; McDonnell, D.; et al. 6G and artificial intelligence technologies for dementia care: Literature review and practical analysis. J. Med. Internet Res. 2022, 24, e30503.
162.
Sharma, A.; Pesarlanka, D.B.; Sharma, S. Harnessing Machine Learning and Deep Learning in Healthcare From Early Diagnosis to Personalized Treatment: Comprehensive Approach of Deep Learning In Healthcare. In AI-Driven Innovation in Healthcare Data Analytics; IGI Global Scientific Publishing: Hershey, PA, USA, 2025; pp. 369–398.
163.
Effendi, Y.; Hidayat, W.; Nurwanda, A. The impact of demographic transition on tax revenue in Indonesia. Scientax 2019, 1, 92–108.
164.
de Lemos Collinson, N.E.C. (2024). Historical Analysis of the Institutional Dynamics Surrounding the Implementation of Health Management Information Systems in Developing Countries: The Case of Mozambique. Ph.D. Thesis, University of Oslo, Oslo, Norway, 2024.
165.
Jakovljevic, M.; Matter-Walstra, K.; Sugahara, T.; et al. Cost-effectiveness and resource allocation (CERA) 18 years of evolution: Maturity of adulthood and promise beyond tomorrow. Cost Eff. Resour. Alloc. 2020, 18, 15.
166.
Farrell, P.; Thow, A.M.; Abimbola, S.; et al. How food insecurity could lead to obesity in LMICs: When not enough is too much: A realist review of how food insecurity could lead to obesity in low-and middle-income countries. Health Promot. Int. 2018, 33, 812–826.
167.
Sujith, R. India’s G20 Presidency: Leading the Charge Towards a Multi-Polar World and a Viksit Bharat. J. East-West Thought 2025, 15, 324–330.
168.
Jawad, M.; Millett, C.; Sullivan, R.; et al. The impact of armed conflict on cancer among civilian populations in low-and middle-income countries: A systematic review. ecancermedicalscience 2020, 14, 1039.
169.
Awuah, W.A.; Tan, J.K.; Shah, M.H.; et al. Addressing abdominal trauma from conflict and warfare in under-resourced regions: A critical narrative review. Health Sci. Rep. 2024, 7, e70151.
Jakovljevic, M.; Ozaki, A.; Lee, M.; Tanimoto, T.; Correia, T.; Teixeira, J. P.; Westerman, R.; Cerda, A.; Kumagai, N.; Ranabhat, C.; Talias, M.; Miyachi, T.; Khatri, R.; Osabohien, R.; Pan, J.; Sahoo, P. M.; Hu, H.; Torrecillas, M. J. M.; Arab-Zozani, M.; Kaneda, Y.; Javan-Noughabi, J.; Jin, H.; Rout, H. S.; Garcia, L.; Yamashita, E.; Ezenduka, C.; Kumara, A. S.; Kouassi, E.; Shahabi, S.; Wu, W.; Adhikari, C.; Kosaka, M.; Tekle, M. G.; Mouselli, S.; Toan, T. K.; Rambaud, S. C.; Ekwunife, O. I.; Wijeratne, T.; Chattu, V. K.; Shi, L. The Global South—Economic History and Health Systems Development. Global South & Sustainable Development2026, 1 (1), 1.
Gray, K.; Gills, B.K. South–South cooperation and the rise of the Global South. Third World Q. 2016, 37, 557–574.
2.
Chant, S.H.; McIlwaine, C. Geographies of Development in the 21st Century: An Introduction to the Global South; Edward Elgar Publishing: Cheltenham, UK, 2009.
3.
Blaut, J.M. 1492: The Debate on Colonialism, Eurocentrism, and History; Africa World Press: Trenton, NJ, USA, 1992.
4.
Peters, M.A. The ancient Silk Road and the birth of merchant capitalism. Educ. Philos. Theory 2021, 53, 955–961.
5.
Burchett, J. A Complete History of the Most Remarkable Transactions at Sea, from the Earliest Accounts of Time to the Conclusion of the Last War with France: Wherein is Given an Account of the... Naval-expeditions, Sea-fights, Stratagems, Discoveries, and Other Maritime Occurences That Have Happen’d Among All Nations Which Have Flourished at Sea; and in a More Particular Manner of Great Britain...: in Five Books; Printed by WB for J. Walthoe and J. Walthoe Junior: London, UK, 1720.
6.
Thompson, T.L. Jerusalem in Ancient History and Tradition; Torrossa: Florence, Italy, 2004; 280p.
7.
Groumpos, P.P. A critical historical and scientific overview of all industrial revolutions. IFAC-Pap. 2021, 54, 464–471.
8.
Spear, B. James Watt: The steam engine and the commercialization of patents. World Pat. Inf. 2008, 30, 53–58.
9.
Fage, J.D. Slavery and the slave trade in the context of West African history. J. Afr. Hist. 1969, 10, 393–404.
10.
Stannard, D. American Holocaust; Oxford University Press: New York, NY, USA, 1992; ISBN 978-0-19-508557-0.
11.
History of Slavery. Available online: https://www.sources.com/SSR/Docs/SSRW-History_Slavery.htm (accessed on 19 October 2025)
12.
Meena, H.K. The Meaning and Methods of Drain of Wealth in Colonial India. Int. Res. J. Manag. IT Soc. Sci. 2016, 3, 65–72.
13.
Bell, N.M. The Age of Mansa Musa of Mali: Problems in succession and chronology. Int. J. Afr. Hist. Stud. 1972, 5, 221–234.
14.
Polo, M. The Travels of Marco Polo, the Venetian; No. 306; JM Dent: London, UK, 1927.
15.
Manning, P. The Maddison project: Historical GDP estimates worldwide. J. World-Hist. Inf. 2017, 3–4. https://doi.org/10.5195/jwhi.2017.46.
16.
Neff, S.C. Decline and emergence: Roman law and the transition from antiquity to feudalism. J. Leg. Hist. 1984, 5, 91–116.
17.
Crafts, N.F. Industrial Revolution in England and France: Some thoughts on the question, “Why was England first?” Econ. Hist. Rev. 1977, 30, 429–441.
18.
Voigtländer, N.; Voth, H.-J. Why England? Demographic factors, structural change and physical capital accumulation during the Industrial Revolution. J. Econ. Growth 2006, 11, 319–361.
19.
Jakovljevic, M.; Cerda, A.A.; Liu, Y.; et al. Sustainability challenge of Eastern Europe—Historical legacy, belt and road initiative, population aging and migration. Sustainability 2021, 13, 11038.
20.
Jakovljevic, M. Population ageing alongside health care spending growth. Srp. Arh. Za Celok. Lek. 2017, 145, 534–539. https://doi.org/10.2298/SARH160906113J.
21.
Wardwell, J.M. Toward a Theory of Urban-Rural Migration in the Developed World. In New Directions in Urban-Rural Migration: The Population Turnaround in rural America; Academic Press: New York, NY, USA, 1980; 71.
22.
Jakovljevic, M.M.; Netz, Y.; Buttigieg, S.C.; et al. Population aging and migration–history and UN forecasts in the EU-28 and its east and south near neighborhood–one century perspective 1950–2050. Glob. Health 2018, 14, 1–6.
23.
Chatterjee, A.; Chattopadhyay, R.N.; Chatterjee, A.; et al. Growth of metropolises and megacities with focus on global south. Satellite Towns in Neo-metropolitan Development in India: Lessons from Selected Cities. J. Urban Aff. 2020, 45, 797–814.
24.
Goldstone, J.A. The Wealth and Poverty of Nations: Why Some Are So Rich and Others So Poor. J. World Hist. 2000, 11, 105–111.
25.
Palat, R.A. World Turned Upside Down? Rise of the global South and the contemporary global financial turbulence. Third World Q. 2010, 31, 365–384.
26.
Gandhi, M. All Men Are Brothers: Life and Thoughts of Mahatma Gandhi as Told in His Own Words; Columbia University Press: New York, NY, USA, 1953. https://doi.org/10.7312/gand90224-006.
27.
Mandela, N. The Struggle Is My Life: His Speeches and Writings Brought Together with Historical Documents and Accounts of Mandela in Prison by Fellow-Prisoners; Popular Prakashan; IDAF Publications: London, UK, 1990.
28.
Rampazzo, B. Le devenir Afrique de Lumumba, Nkrumah et Sankara. Ou de l’importance de ressasser le passé contre le discours de Dakar: Pages: 218–237. Philos. Soc. 2012, 23. https://doi.org/10.2298/FID1204218R.
29.
Lüthi, L.M. The non-aligned movement and the cold war, 1961–1973. J. Cold War Stud. 2016, 18, 98–147.
30.
Simonia, N.A. National liberation movements and the collapse of colonialism. In History of Humanity: The Twentieth Century 7; Government of India Mission to ASEAN: Jakarta, Indonesia, 1994; pp. 56–61.
31.
Berryman, P. Liberation Theology: Essential Facts about the Revolutionary Movement in Latin America—And Beyond; Temple University Press: Philadelphia, PA, USA, 1987.
32.
Andjembe Etogho, E.B.; Eben, S.E.M.; Dalton, A.L. French neocolonialism in Africa: Historical overview and summary of current events. Am. J. Econ. Sociol. 2022, 81, 829–849.
33.
Musa, A.A.; Awudu, A.D.; Elijah, E. Neo-Colonialism and Dependent Development in African Countries: A Critical Analysis of Nigeria’s Neo-Colonial Status. Kashere J. Politics Int. Relat. 2025, 3, 283–295.
34.
Yoon, T.-R. Historical animosity is what states make of it: The role of morality and realism in Korea-Japan relations. Korean J. Int. Stud. 2011, 9, 1–37.
35.
Bull, H. The great irresponsibles? The United States, the Soviet Union, and world order. Int. J. 1980, 35, 437–447.
36.
Lu, X.; Li, R. South-South cooperation: Is there a foundation in trade? J. Chin. Econ. Foreign Trade Stud. 2010, 3, 221–234.
37.
Hurrell, A. Narratives of emergence: Rising powers and the end of the Third World? Braz. J. Political Econ. 2013, 33, 203–221.
38.
The Voice of Global South Summit: Participation of ASEAN Member States. Available online: https://www.indmissionasean.gov.in/press_india?id=dPjza (accessed on 19 October 2025).
39.
Kumar, S. India’s G20 Presidency as a Voice of Global South; RIS, Research and Information System for Developing Countries: New Delhi, India, 2024.
40.
Dinkel, J. The Non-Aligned Movement: Genesis, Organization and Politics (1927–1992); Brill: Leiden, The Netherlands, 2018; Volume 5.
41.
Finance Center for South-South Cooperation. Available online: http://www.fc-ssc.org/en (accessed on 19 October 2025).
42.
The Group of 77.Available online: https://www.g77.org/ (accessed on 19 October 2025).
43.
Tulchinsky, T.H. Bismarck and the long road to universal health coverage. Case Stud. Public Health 2018, 131–179. https://doi.org/10.1016/B978-0-12-804571-8.00031-7.
44.
Jacobs, J. An introduction to the Beveridge Report. In Understanding Health and Social Care: An Introductory Reader; SAGE Publications: Thousand Oaks, CA, USA, 2008.
45.
Semenova, Y.; Lim, L.; Salpynov, Z.; et al. Historical evolution of healthcare systems of post-soviet Russia, Belarus, Kazakhstan, Kyrgyzstan, Tajikistan, Turkmenistan, Uzbekistan, Armenia, and Azerbaijan: A scoping review. Heliyon 2024, 10, e29550. https://doi.org/10.1016/j.heliyon.2024.e29550.
46.
Reshetnikov, V.; Arsentyev, E.; Bolevich, S.; et al. Analysis of the financing of Russian health care over the past 100 years. Int. J. Environ. Res. Public Health 2019, 16, 1848.
47.
Hariri, J.G. The autocratic legacy of early statehood. Am. Political Sci. Rev. 2012, 106, 471–494.
48.
Santini, R.H.; Polese, A.; Kevlihan, R. (Eds.) Limited Statehood and Informal Governance in the Middle East and Africa; Routledge, Taylor & Francis Group: London, UK, 2021.
49.
Allahham, L.; Mouselli, S.; Jakovljevic, M. The quality of Syrian healthcare services during COVID-19: A HEALTHQUAL approach. Front. Public Health 2022, 10, 970922.
50.
Nelson, M.A.; Singh, R.D. The deficit-growth connection: Some recent evidence from developing countries. Econ. Dev. Cult. Chang. 1994, 43, 167–191.
51.
Reeves, A.; Basu, S.; McKee, M.; et al. Does investment in the health sector promote or inhibit economic growth? Glob. Health 2013, 9, 43.
52.
Panda, H.S.; Rout, H.S.; Jakovljevic, M. Catastrophic health expenditure of inpatients in emerging economies: Evidence from the Indian subcontinent. Health Res. Policy Syst. 2024, 22, 104.
53.
Miyachi, T.; Ozaki, A.; Jakovljevic, M.; et al. Fiscal Resilience and Equity: Analyzing Japan’s Tax Strategy for Post-Disaster Reconstruction. Int. J. Disaster Risk Reduct. 2025, 118, 105228.
54.
Otieno, E.; Seeiso, T.; Businge, J.; et al. Achieving universal health coverage in Sub-Saharan Africa through the reformation of mental health financing. Glob. Health Econ. Sustain. 2025, 3, 21–27 https://doi.org/10.36922/ghes.3700.
55.
Kalita, A.; Carton-Rossen, N.; Joseph, L.; et al. The Barriers to Universal Health Coverage in India and the Strategies to Address Them: A Key Informant Study. Ann. Glob. Health 2023, 89, 69. https://doi.org/10.5334/aogh.4120.
56.
Jyani, G.; Gedam, P.; Sharma, S.; et al. Financial Viability of Private Hospitals Operating Under India’s National Health Insurance Scheme Ayushman Bharat Pradhan Mantri-Jan Arogya Yojana (AB PM-JAY). Appl. Health Econ. Health Policy 2025, 23, 841–853. https://doi.org/10.1007/s40258-025-00966-9.
57.
Khan, M.A. Livelihood, WASH related hardships and needs assessment of climate migrants: Evidence from urban slums in Bangladesh, Heliyon 2022, 8, e09355. https://doi.org/10.1016/j.heliyon.2022.e09355.
58.
Jakovljevic, M.; Deceuninck, P.; Pistollato, F.; et al. Return on investment in science: Twenty years of European Commission funded research in Alzheimer’s dementia, breast cancer and prostate cancer. Cost Eff. Resour. Alloc. 2024, 22, 51.
59.
Fenollar, F.; Mediannikov, O. Emerging infectious diseases in Africa in the 21st century. New Microbes New Infect. 2018, 26, S10–S18.
60.
Jakovljevic, M.; Al Ahdab, S.; Jurisevic, M.; et al. Antibiotic resistance in Syria: A local problem turns into a global threat. Front. Public Health 2018, 6, 212.
61.
Vecchio, F.B.D.; Barbosa, E.P.; Cantu, R. Max Weber and Harriet Martineau in physical education: Nuances of historical parallelism and gender bias in the sociological method. Glob. Health Econ. Sustain. 2023, 1, 0992. https://doi.org/10.36922/ghes.0992.
62.
Popkin, B.M.; Ng, S.W. The nutrition transition to a stage of high obesity and noncommunicable disease prevalence dominated by ultra-processed foods is not inevitable. Obes. Rev. 2022, 23, e13366.
63.
Alkholidy, G.G.; Anam, L.S.; Al Serouri, A.; et al. Non-communicable diseases household survey data analysis in Sana’a City, Yemen, 2017. Glob. Health Econ. Sustain. 2023, 1, 1191. https://doi.org/10.36922/ghes.1191.
64.
Jakovljevic, M.; Kozlova, O.; Makarova, M.; et al. Partial contribution of socioeconomic factors to the mortality rate of the working-age population in Russia. Healthcare 2023, 11, 1507.
65.
Goda, E.T.; Boshera, T.D.; Aredo, M.K. Examining the relationship between urban household food Insecurity and under-five mortality in Lideta Sub-city, Addis Ababa, Ethiopia. Glob. Health Econ Sustain 2024, 2, 1682. https://doi.org/10.36922/ghes.1682.
66.
Kovačević, A.; Dragojević-Simić, V.; Rančić, N.; et al. End-of-life costs of medical care for advanced stage cancer patients. Vojnosanit. Pregl. 2015, 72. https://doi.org/10.2298/5439.
67.
Amza, A. Sustainability of specialized healthcare in economies like Jamaica: Overcoming historical constraints. Glob. Health Econ. Sustain. 2024, 2, 2709. https://doi.org/10.36922/ghes.2709.
68.
Liu, L. Economic uncertainty and population health: Insights from emerging markets and developing countries. Front. Public Health 2023, 11, 1292236.
69.
Chen, X.; Cai, K.; Xue, Y.; et al. Using system dynamics modeling approach to strengthen health systems to combat cancer: A systematic literature review. J. Med. Econ. 2025, 28, 168–185.
70.
Shi, L.; Xuan, D.; Jakovljevic, M. A review on the evolving environment of medical device real-world evidence regulation on market access in the USA. Cost Eff. Resour. Alloc. 2024, 22, 75.
71.
Jakovljevic, M.; Sahoo, P.M.; Rout, H.S. Health expenditure and fiscal marksmanship before and during the coronavirus pandemic across the federal states of India. Glob. Health Econ. Sustain. 2025, 3, 135–149. https://doi.org/10.36922/ghes.2920.
72.
Blackstone, E.A.; Fuhr, J.P., Jr.; Pociask, S. The health and economic effects of counterfeit drugs. Am. Health Drug Benefits 2014, 7, 216.
73.
Glass, B.D. Counterfeit drugs and medical devices in developing countries. Res. Rep. Trop. Med. 2014, 5, 11–22.
74.
Fantasia, H.C.; Vooys, K.M. Public health implications of counterfeit medications. Nurs. Women’s Health 2018, 22, 264–268.
75.
Delepierre, A.; Gayot, A.; Carpentier, A. Update on counterfeit antibiotics worldwide; public health risks. Med. Mal. Infect. 2012, 42, 247–255.
76.
Mackey, T.K.; Liang, B.A. Improving global health governance to combat counterfeit medicines: A proposal for a UNODC-WHO-Interpol trilateral mechanism. BMC Med. 2013, 11, 233.
77.
Mackey, T.K.; Liang, B.A. The global counterfeit drug trade: Patient safety and public health risks. J. Pharm. Sci. 2011, 100, 4571–4579.
78.
Hamilton, W.L.; Doyle, C.; Halliwell-Ewen, M.; et al. Public health interventions to protect against falsified medicines: A systematic review of international, national and local policies. Health Policy Plan. 2016, 31, 1448–1466.
79.
Martí Selva, M.L.; Puertas Medina, R.M. Determinants of the imports of essential medical products by European Union. Glob. Health Econ. Sustain. 2023, 1. https://doi.org/10.36922/ghes.1207.
80.
Awor, P.; Kinengyere, A.A. Delivering maternal and child health interventions through the private sector in LMIC: A scoping review of strategies and effective approaches. BMJ Public Health 2023, 1, e000088. https://doi.org/10.1136/bmjph-2023-000088.
81.
Kodali, P.B. Achieving Universal Health Coverage in Low- and Middle-Income Countries: Challenges for Policy Post-Pandemic and Beyond. Risk Manag. Healthc. Policy 2023, 16, 607–621. https://doi.org/10.2147/RMHP.S366759.
82.
Idris, F.M.; Seraj, M.; Ozdeser, H. Impact of health expenditure on poverty in low- and middle-income countries: An autoregressive distributed lag bounds approach. Glob. Health Econ. Sustain. 2024, 2, 2383. https://doi.org/10.36922/ghes.2383.
83.
Jakovljevic, M.; Lamnisos, D.; Westerman, R.; et al. Future health spending forecast in leading emerging BRICS markets in 2030: Health policy implications. Health Res. Policy Syst. 2022, 20, 23.
84.
Arapova, E.Y.; Lissovolik, Y.D. The BRICS plus cooperation in international organizations: Prospects for reshaping the global agenda. Asia-Pac. Soc. Sci. Rev. 2021, 21, 14.
85.
Li, J.; Xu, Z.; Wang, H.; et al. Geospatial analysis of spatial distribution, patterns, and relationships of health status in the belt and road initiative. Sci. Rep. 2024, 14, 204.
86.
Amza, A. Sustainability of specialized healthcare in upper-middle-income economies: Innovations despite constraints. Glob. Health Econ. Sustain. 2024, 2, 2717. https://doi.org/10.36922/ghes.2717.
87.
Gasper, D. The road to the sustainable development goals: Building global alliances and norms. J. Glob. Ethics 2019, 15, 118–137.
88.
Stevens, H.; Huys, I. Innovative approaches to increase access to medicines in developing countries. Front. Med. 2017, 4, 218. https://doi.org/10.3389/fmed.2017.00218.
89.
Dinh, S.; Yin, W.; Sifre-Acosta, N.; et al. COVID-19 pandemic health expenditures and family economic behaviors: China health and retirement longitudinal study (CHARLS). Glob. Health Econ. Sustain. 2025, 3, 203–213. https://doi.org/10.36922/ghes.6619.
90.
Niëns, L.M.; Cameron, A.; Van de Poel, E.; et al. Quantifying the impoverishing effects of purchasing medicines: A cross-country comparison of the affordability of medicines in the developing world. PLoS Med. 2010, 7, e1000333.
91.
Choi, H.C.; Lam, K.O.; Pang, H.H.; et al. Global comparison of cancer outcomes: Standardization and correlation with healthcare expenditures. BMC Public Health 2019, 19, 1065.
92.
Johnston, K.; Guingona, M.; Elsanousi, S.; et al. Training a fit-for-purpose rural health workforce for low-and middle-income countries (LMICs): How do drivers and enablers of rural practice intention differ between learners from LMICs and high income countries? Front. Public Health 2020, 8, 582464.
93.
Jakovljevic, M.; Sharma, T.; Kumagai, N.; et al. NCDs–core challenge of modern day health care establishments. Front. Public Health 2021, 9, 692926. https://doi.org/10.3389/fpubh.2021.692926.
94.
Al Ahdab, S. A cross-sectional survey of knowledge, attitude and practice (KAP) towards COVID-19 pandemic among the Syrian residents. BMC Public Health 2021, 21, 296.
95.
Leech, A.A.; Kim, D.D.; Cohen, J.T.; et al. Are low and middle-income countries prioritising high-value healthcare interventions? BMJ Glob. Health 2020, 5, e001850.
96.
Jakovljevic, M.; Timofeyev, Y.; Zhuravleva, T. The impact of pandemic-driven care redesign on hospital efficiency. Risk Manag. Healthc. Policy 2024, 17, 1477–1491.
97.
Timofeyev, Y.; Jakovljevic, M. Fraud and corruption in healthcare. Front. Public Health 2022, 10, 921254. https://doi.org/10.3389/fpubh.2022.921254.
98.
Ozaki, A.; Larkin, J.; Sakata, N.; et al. Unveiling, analyzing the mechanisms of, and proposing solutions for bribery in Japan’s medical device sector. Cureus 2024, 16, e61285.
99.
Hutson, J.; Hutson, P. Neuroinclusive workplaces and biophilic design: Strategies for promoting occupational health and sustainability in smart cities. Glob. Health Econ. Sustain. 2023, 1, 491. https://doi.org/10.36922/ghes.0549.
100.
Kindle, R.D.; Badawi, O.; Celi, L.A.; et al. Intensive care unit telemedicine in the era of big data, artificial intelligence, and computer clinical decision support systems. Crit. Care Clin. 2019, 35, 483–495.
101.
Atmojo, J.T.; Sudaryanto, W.T.; Widiyanto, A.; et al. Telemedicine, cost effectiveness, and patients satisfaction: A systematic review. J. Health Policy Manag. 2020, 5, 103–107.
102.
Jakovljevic, M.; Sugahara, T.; Timofeyev, Y.; et al. Predictors of (in) efficiencies of healthcare expenditure among the leading as an economies–comparison of OECD and non-OECD nations. Risk Manag. Healthc. Policy 2020, 13, 2261–2280.
103.
John, D.; Majumdar, A.D.; Pillai, R.N.; et al. Health technology assessment for digital health Technologies in India: A framework for action. Int. J. Technol. Assess. Health Care 2024, 40, e70.
104.
Christine, C. Huttin. Are random price generators useful for health policy processes and analysis? effectiveness of random price generators in health policy processes and analysis. Glob. Health Econ. Sustain. 2025, 3, 28–36. https://doi.org/10.36922/ghes.3579.
105.
Kumar, A.S.; Chen, L.C.; Choudhury, M.; et al. Financing health care for all: Challenges and opportunities. Lancet 2011, 377, 668–679.
106.
Leighl, N.B.; Nirmalakumar, S.; Ezeife, D.A.; et al. (2021). An arm and a leg: The rising cost of cancer drugs and impact on access. In American Society of Clinical Oncology Educational Book; ASCO Publications: Alexandria, VA, USA, 2021; Volume 41, pp. 1–12.
107.
Barrios, C.; de Lima Lopes, G.; Md Yusof, M.; et al. Barriers in access to oncology drugs—A global crisis. Nat. Rev. Clin. Oncol. 2023, 20, 7–15.
108.
Yenet, A.; Nibret, G.; Tegegne, B.A. Challenges to the availability and affordability of essential medicines in African countries: A scoping review. Clin. Outcomes Res. 2023, 15, 443–458.
109.
Borin, M.C.; Barbosa, M.M.; Pereira, C.O.; et al. Budgetary impact of new label indications after initial drug registration in Brazil: A case study of pembrolizumab and trastuzumab deruxtecan. Glob. Health Econ. Sustain. 2023, 1, 0994. https://doi.org/10.36922/ghes.0994.
110.
Lexchin, J. Profits first, health second: The pharmaceutical industry and the Global South: Comment on “More pain, more gain! The delivery of COVID-19 vaccines and the pharmaceutical industry’s role in widening the access gap”. Int. J. Health Policy Manag. 2024, 13, 8471.
111.
Barber, M.J.; Gotham, D.; Bygrave, H.; et al. Estimated sustainable cost-based prices for diabetes medicines. JAMA Netw. Open 2024, 7, e243474.
112.
Ghosh, M.; Yadav, A.K.; Sahni, B. Income inequalities in maternal health-care service utilization in India: Applying the Blinder–Oaxaca decomposition method. Glob. Health Econ. Sustain. 2025, 3, 92–101. https://doi.org/10.36922/ghes.3324.
113.
Binagwaho, A.; Mathewos, K.; Davis, S. Time for the ethical management of COVID-19 vaccines. Lancet Glob. Health 2021, 9, e1169–e1171.
114.
Borin, M.C.; Barbosa, M.M.; Pereira, C.O.; et al. Assessing the impact of fast-track drug registration by Anvisa in Brazil: A descriptive study of new drug registrations from 2017 to 2022. Glob. Health Econ. Sustain. 2023, 1, 0995. https://doi.org/10.36922/ghes.0995.
115.
World Trade Organization. Uruguay Round Agreement: TRIPS—Agreement on Trade-Related Aspects of Intellectual Property Rights (unamended). Marrakesh Agreement Establishing the World Trade Organization, Annex 1C. 1994. Available online: https://www.wto.org/english/docs_e/legal_e/27-trips.pdf (accessed on 25 September 2025).
116.
Kohler, J.; Wong, A.; Tailor, L. Improving access to COVID-19 vaccines: An analysis of TRIPS waiver discourse among WTO members, civil society organizations, and pharmaceutical industry stakeholders. Health Hum. Rights 2022, 24, 159–175.
117.
Odo, O.K.; Gulma, K.A.; & Audi, M. Optimizing last-mile delivery of essential medicines in Nigeria: Insights from Niger State’s Healthcare supply chain. Glob. Health Econ. Sustain. 2024, 3, 185–196. https://doi.org/10.36922/ghes.4714.
118.
World Health Organization. Essential Medicines. 25 September 2024. Available online: https://www.who.int/news-room/fact-sheets/detail/essential-medicines (accessed on 25 September 2025).
119.
Torreele, E. Why are our medicines so expensive? Spoiler: Not for the reasons you are being told…. J. Gen. Pract. 2024, 30, 2308006.
120.
Jakovljevic, M.; Liu, Y.; Cerda, A.; et al. The Global South political economy of health financing and spending landscape—History and presence. J. Med. Econ. 2021, 24, 25–33.
121.
Oldfield, L.; Penm, J.; Mirzaei, A.; et al. Prices, availability, and affordability of adult medicines in 2025, 54 low-income and middle-income countries: Evidence based on a secondary analysis. Lancet Glob. Health 2025, 13, e50–e58.
122.
Collins, L.; Ross, L.; Preston, M. Cost-effectiveness of promoting population health management through education, seminars, and participatory learning for individuals diagnosed with chronic diseases. Glob. Health Econ. Sustain. 2025, 3, 64–68. https://doi.org/10.36922/ghes.3089.
123.
Lavtepatil, S.; Ghosh, S. Improving access to medicines by popularising generics: A study of ‘India’s People’s Medicine’ scheme in two districts of Maharashtra. BMC Health Serv. Res. 2022, 22, 643. https://doi.org/10.1186/s12913-022-08022-1.
124.
Chen, Y.; Huang, Z. Differences between the quality aspects of various generic and branded docetaxel formulations. Curr. Med. Res. Opin. 2021, 37, 1421–1433. https://doi.org/10.1080/03007995.2021.1929895.
125.
Lam, D. How the world survived the population bomb: Lessons from 50 years of extraordinary demographic history. Demography 2011, 48, 1231–1262.
126.
Gu, D.; Andreev, K.; Dupre, M.E. Major trends in population growth around the world. China CDC Wkly. 2021, 3, 604.
127.
Allyn, D. Make Love, Not War: The Sexual Revolution: An Unfettered History; Routledge: New York, NY, USA, 2016. https://doi.org/10.4324/9781315539768.
128.
Shorter, E. Female emancipation, birth control, and fertility in European history. Am. Hist. Rev. 1973, 78, 605–640.
129.
Maier, C.S. The Cold War as an era of imperial rivalry. In Reinterpreting the End of the Cold War; pp. 13–20. Routledge: New York, NY, USA, 2014.
130.
Hemmati, R.; Saboori, H.; Jirdehi, M.A. Multistage generation expansion planning incorporating large scale energy storage systems and environmental pollution. Renew. Energy 2016, 97, 636–645.
131.
Kao, J. Innovation Nation: How America Is Losing Its Innovation Edge, Why It Matters, and What We Can Do to Get It Back; Simon and Schuster: New York, NY, USA, 2007.
132.
Tregubov, V.N. Publication activity of researchers about the NA Semashko’s life and activity Health Сare Russ. Fed. 2024, 68, 241–246.
133.
Jakovljevic, M.; Ogura, S. Health economics at the crossroads of centuries–from the past to the future. Front. Public Health 2016, 4, 115. https://doi.org/10.3389/fpubh.2016.00115.
134.
Jensen, S.K.; Bouhouch, R.R.; Walson, J.L.; et al. Enhancing the child survival agenda to promote, protect, and support early child development. Semin. Perinatol. 2015, 39, 373–386.
135.
Jasseh, M. Age Patterns of Mortality within Childhood in Sub-Saharan Africa. Doctoral Dissertation, London School of Hygiene & Tropical Medicine, London, UK, 2003.
136.
Jakovljevic, M.; Péntek, M.; Wijeratne, T.; et al. Accelerated globalization and its impact to the world’s Health Care Achievement. Front. Public Health 2021, 9, 690239. https://doi.org/10.3389/fpubh.2021.690239.
137.
Jakovljevic, M.B. BRIC’s growing share of global health spending and their diverging pathways. Front. Public Health 2015, 3, 135. https://doi.org/10.3389/fpubh.2015.00135.
138.
Jakovljevic, M.; Chang, H.; Pan, J.; et al. Successes and challenges of China’s health care reform: A four-decade perspective spanning 1985—2023. Cost Eff. Resour. Alloc. 2023, 21, 59.
139.
Hogg, W.; Baskerville, N.; Lemelin, J. Cost savings associated with improving appropriate and reducing inappropriate preventive care: Cost-consequences analysis. BMC Health Serv. Res. 2005, 5, 20.
140.
Rahman, T.; Gasbarro, D.; Alam, K. Financial risk protection from out-of-pocket health spending in low-and middle-income countries: A scoping review of the literature. Health Res. Policy Syst. 2022, 20, 83.
141.
Sumner, A. The Buoyant Billions: How’Middle Class’ are the New Middle Classes in Developing Countries? (And Why Does it Matter?). Center for Global Development Working Paper 309. 2012. Available online: https://ssrn.com/abstract=2226568 (accessed on 25 September 2025).
142.
Schrecker, T. (2021). Health inequalities and development in a global context. In The Essential Guide to Critical Development Studies; Routledge: London, UK, 2021; pp. 213–221.
143.
Guy-Frank, C.J.; Persaud, K.; Butsenko, D.; et al. Developing a sustainable renal transplant program in low-and middle-income countries: Outcome, challenges, and solutions. World J. Surg. 2019, 43, 2658–2665.
144.
Cui, A.P.; Wajda, T.A.; Walsh, M.F. Luxury brands in emerging markets: A case study on China. In Entrepreneurship in International Marketing; Emerald Group Publishing Limited: Bingley, UK, 2015; pp. 287–305.
145.
Khan, M.A.; Ul Husnain, M.I. Is health care a luxury or necessity good? Evidence from Asian countries. Int. J. Health Econ. Manag. 2019, 19, 213–233.
146.
Sumner, A. Poverty, vulnerability and class: The expanding non-polar groups and development. Public Adm. Dev. 2012, 32, 444–454.
147.
Petrou, S.; Jakovljevic, M. Reimagining the relationship between economics and health—WHO ‘Health for all’ provisions. Cost Eff. Resour. Alloc. 2024, 22, 5. https://doi.org/10.1186/s12962-024-00512-9.
148.
Ogura, S.; Jakovljevic, M. Health financing constrained by population aging-an opportunity to learn from Japanese experience. Serbian J. Exp. Clin. Res. 2014, 15, 175–181 https://doi.org/10.2478/SJECR-2014-0022.
149.
Luo, Y.; Su, B.; Zheng, X. Trends and challenges for population and health during population aging—China, 2015–2050. China CDC Wkly. 2021, 3, 593.
150.
Katoue, M.G.; Cerda, A.A.; García, L.Y.; et al. Healthcare system development in the Middle East and North Africa region: Challenges, endeavors and prospective opportunities. Front. Public Health 2022, 10, 1045739. https://doi.org/10.3389/fpubh.2022.1045739.
151.
Jakovljevic, M.; Jakab, M.; Gerdtham, U.; et al. Comparative financing analysis and political economy of noncommunicable diseases. J. Med. Econ. 2019, 22, 722–727.
152.
Jakovljevic, M. Therapeutic innovations: The future of health economics and outcomes research–increasing role of the Asia-Pacific. J. Med. Econ. 2021, 24, i–iii. https://doi.org/10.1080/13696998.2021.2014164.
153.
Allen, L.N.; Pullar, J.; Wickramasinghe, K.K.; et al. Evaluation of research on interventions aligned to WHO ‘Best Buys’ for NCDs in low-income and lower-middle-income countries: A systematic review from 1990 to 2015. BMJ Glob. Health 2018, 3, e000535..
154.
Nash, C. Promoting sustainability through equality, peace, and justice: A luck-dependent decision-making practice in an economically successful intentional community. Glob. Health Econ. Sustain. 2024, 2, 3191. https://doi.org/10.36922/ghes.3191.
155.
Raghupathi, W.; Wu, S.J.; Raghupathi, V. Exploring the association between gender inequality and healthcare: A visualization study. Glob. Health Econ. Sustain. 2025, 3, 188–202. https://doi.org/10.36922/ghes.5776.
156.
Jakovljevic, M.; Wu, W.; Merrick, J.; et al. Asian innovation in pharmaceutical and medical device industry–beyond tomorrow. J. Med. Econ. 2021, 24, 42–50.
157.
Mashamba-Thompson, T.P.; Jama, N.A.; Sartorius, B.; et al. Implementation of point-of-care diagnostics in rural primary healthcare clinics in South Africa: Perspectives of key stakeholders. Diagnostics 2017, 7, 3.
158.
Cerda, A.A.; García, L.Y.; Rivera-Arroyo, J.; et al. Comparison of the healthcare system of Chile and Brazil: Strengths, inefficiencies, and expenditures. Cost Eff. Resour. Alloc. 2022, 20, 71.
159.
Barnes, R.; Zvarikova, K. Artificial intelligence-enabled wearable medical devices, clinical and diagnostic decision support systems, and Internet of Things-based healthcare applications in COVID-19 prevention, screening, and treatment. Am. J. Med. Res. 2021, 8, 9–22.
160.
Croll, E.J. The intergenerational contract in the changing Asian family. Oxf. Dev. Stud. 2006, 34, 473–491.
161.
Su, Z.; Bentley, B.L.; McDonnell, D.; et al. 6G and artificial intelligence technologies for dementia care: Literature review and practical analysis. J. Med. Internet Res. 2022, 24, e30503.
162.
Sharma, A.; Pesarlanka, D.B.; Sharma, S. Harnessing Machine Learning and Deep Learning in Healthcare From Early Diagnosis to Personalized Treatment: Comprehensive Approach of Deep Learning In Healthcare. In AI-Driven Innovation in Healthcare Data Analytics; IGI Global Scientific Publishing: Hershey, PA, USA, 2025; pp. 369–398.
163.
Effendi, Y.; Hidayat, W.; Nurwanda, A. The impact of demographic transition on tax revenue in Indonesia. Scientax 2019, 1, 92–108.
164.
de Lemos Collinson, N.E.C. (2024). Historical Analysis of the Institutional Dynamics Surrounding the Implementation of Health Management Information Systems in Developing Countries: The Case of Mozambique. Ph.D. Thesis, University of Oslo, Oslo, Norway, 2024.
165.
Jakovljevic, M.; Matter-Walstra, K.; Sugahara, T.; et al. Cost-effectiveness and resource allocation (CERA) 18 years of evolution: Maturity of adulthood and promise beyond tomorrow. Cost Eff. Resour. Alloc. 2020, 18, 15.
166.
Farrell, P.; Thow, A.M.; Abimbola, S.; et al. How food insecurity could lead to obesity in LMICs: When not enough is too much: A realist review of how food insecurity could lead to obesity in low-and middle-income countries. Health Promot. Int. 2018, 33, 812–826.
167.
Sujith, R. India’s G20 Presidency: Leading the Charge Towards a Multi-Polar World and a Viksit Bharat. J. East-West Thought 2025, 15, 324–330.
168.
Jawad, M.; Millett, C.; Sullivan, R.; et al. The impact of armed conflict on cancer among civilian populations in low-and middle-income countries: A systematic review. ecancermedicalscience 2020, 14, 1039.
169.
Awuah, W.A.; Tan, J.K.; Shah, M.H.; et al. Addressing abdominal trauma from conflict and warfare in under-resourced regions: A critical narrative review. Health Sci. Rep. 2024, 7, e70151.